🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Charles River Laboratories International, Inc.

CRL Healthcare
$172.5 +$12.78 (8.00%)
Market Cap: $8.49 B
Gurus Holding
10
Popularity Rank
#416
% of Shares Held
4.32%
Net Activity (Q4 2025)
-$37.74 M

Guru Ownership Trend

Guru Analysis for Charles River Laboratories International, Inc. (CRL)

Charles River Laboratories International, Inc. (CRL), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 10 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $366.78 M.

Top institutional holders include John Rogers and Joel Greenblatt.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $37.74 M net outflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Paul Tudor Jones reduced exposure by 94.8%.

Key Holders

Top 5 by Value

$284.81 M
$57.75 M
$44.2 M
$23.96 M
$4.4 M

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$48.02 M
Total Buy Value
New Buys 3
Additions 1
-$85.76 M
Total Sell Value
Reductions 6
Sold Out 2

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
8
Net Buyers
4

FAQs for Charles River Laboratories International, Inc. (CRL)

Major holders include John Rogers ($284.81 M), Joel Greenblatt ($57.75 M), Steven Cohen ($44.2 M). According to the latest reported data, 10 tracked investment managers collectively hold approximately 2.13 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $37.74 M, with 4 managers increasing positions and 8 managers reducing holdings.

During the most recent reporting period, 6 managers trimmed their positions, while 2 fully exited CRL. The total reported sell value was $85.76 M.

Yes, 3 managers opened new positions in CRL, and 1 increased their existing holdings. The total reported buy value was $48.02 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
3.08% Reduce -4.2% 1,427,771 $284.81 M Q4 2025
0.21% Reduce -8.3% 289,516 $57.75 M Q4 2025
0.05% New Buy 221,592 $44.2 M Q4 2025
0.01% Reduce -54.7% 120,112 $23.96 M Q4 2025
0.02% Add 10.8% 22,054 $4.4 M Q4 2025
0.03% Reduce -2.6% 12,580 $2.51 M Q4 2025
0.03% Reduce -77.7% 10,903 $2.17 M Q4 2025
0.00% New Buy 10,200 $2.03 M Q4 2025
0.02% New Buy 6,778 $1.35 M Q4 2025
0.00% Reduce -94.8% 4,782 $953,913 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form